Tätigkeitsbericht 2007/2008

Total Page:16

File Type:pdf, Size:1020Kb

Tätigkeitsbericht 2007/2008 Tätigkeitsbericht 2007/2008 8 200 / 7 0 20 Tätigkeitsbericht Stiftung bürgerlichen Rechts Martinistraße 52 · 20251 Hamburg Tel.: +49 (0) 40 480 51-0 · Fax: +49 (0) 40 480 51-103 [email protected] · www.hpi-hamburg.de Impressum Verantwortlich Prof. Dr. Thomas Dobner für den Inhalt Dr. Heinrich Hohenberg Redaktion Dr. Angela Homfeld Dr. Nicole Nolting Grafik & Layout AlsterWerk MedienService GmbH Hamburg Druck Hartung Druck + Medien GmbH Hamburg Titelbild Neu gestaltete Fassade des Seuchenlaborgebäudes Tätigkeitsbericht 2007/2008 Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie an der Universität Hamburg Martinistraße 52 · 20251 Hamburg Postfach 201652 · 20206 Hamburg Telefon: +49-40/4 80 51-0 Telefax: +49-40/4 80 51-103 E-Mail: [email protected] Internet: www.hpi-hamburg.de Das Heinrich-Pette-Institut ist Mitglied der Leibniz-Gemeinschaft (WGL) Internet: www.wgl.de Inhaltsverzeichnis Allgemeiner Überblick Vorwort ................................................................................................... 1 Die Struktur des Heinrich-Pette-Instituts .............................................. 2 Modernisierung des HPI erfolgreich abgeschlossen ............................ 4 60 Jahre HPI .............................................................................................. 5 Offen für den Dialog .............................................................................. 6 Preisverleihungen und Ehrungen .......................................................... 8 Personelle Veränderungen in den Jahren 2007 und 2008 ................... 10 Wissenschaftliche Highlights ................................................................. 12 Hohes Drittmittelaufkommen am HPI ................................................... 16 HPI fördert wissenschaftlichen Nachwuchs .......................................... 19 Gleichstellungsinitiative am HPI ............................................................ 22 Das „Leibniz Center for Infection“ (LCI) ................................................ 23 Programmbereich „Virus-Wirts-Wechselwirkungen“ Program Area “Virus-Host Interaction”* Introduction ............................................................................................. 27 Research Projects ..................................................................................... 29 ■ Helper function of wild-type p53 in Simian virus 40 induced cellular transformation ........................................................................... 29 ■ Role of c-Met in SV40-induced mammary tumorigenesis ....................... 30 ■ Mutant p53 gain of function in mammary carcinogenesis ...................... 32 ■ A preclinical model for monitoring treatment and prevention of metastasis in mammary carcinoma .................................................... 33 ■ Induction of a cellular immune response against SV40 induced mammary carcinoma in transgenic mice ................................... 34 ■ Steroid dependent control of HIV replication .......................................... 35 ■ Control of viral mRNA export by adenovirus regulatory proteins ............ 36 ■ Identification of a new substrate of the adenovirus/E1B-55K/E4orf6 ubiquitin ligase complex ......................................................................... 39 ■ Human adenovirus E4 region orf3/4 protein is required for efficient virus replication ................................................................... 40 ■ Localization and importance of the adenovirus E4orf4 protein during lytic infection .............................................................................. 41 ■ Intrinsic disorder in the amino terminus of human adenovirus type 5 E1B-55K and its related proteins ................................................. 42 ■ A novel 49K isoform of the adenovirus type 5 early region 1B 55K protein is sufficient to support viral replication ........................... 43 ■ Daxx-mediated negative regulation of adenovirus replication is counteracted by the adenovirus E1B-55K protein .............. 43 ■ Posttranscriptional processing of HIV-1 mRNA ........................................ 44 *Titel im Inhaltsverzeichnis sind z. T. gekürzt aufgelistet. ■ Combating drug resistance in HIV-1 infection ........................................ 47 ■ Eradication of HIV-1 proviral DNA from patient cells .............................. 49 ■ Rapid response kinetics to HLA-B57/58 Gag-restricted CTL epitopes is associated with slow disease progression in chronic HIV-1 infection .... 51 ■ Determinants of successful antiviral treatment of concomitant acute HCV/HIV coinfection ..................................................................... 53 ■ Crossing the Species Barrier: Role of Env-Receptor Interactions in Gammaretrovirus Infections ................................................................ 54 ■ Requirement of Activation for Hepatitis B Virus Infection ....................... 55 ■ Enzymatic treatment of duck hepatitis B virus: topology of the surface proteins for virions and noninfectious subviral particles .............. 55 ■ Entry of Duck Hepatitis B Virus into Primary Duck Liver and Kidney Cells .................................................................................... 55 ■ Elucidation of the SV40-induced DNA damage signaling cascades and their components utilized by SV40 .................................................. 56 ■ Role of the host’s p53 status in SV40 life cycle ....................................... 57 ■ Elucidation of the molecular mechanisms that underlie SV40-induced polyploidization ............................................................... 58 ■ Inhibition of duck hepatitis B virus infection of liver cells by combined treatment with viral e antigen and carbohydrates ............. 59 ■ Solution structure of stem-loop alpha of the hepatitis B virus post-transcriptional regulatory element .................................................. 60 ■ Analysis of Duck Hepatitis B Virus core protein phosphorylation and dephosphorylation ........................................................................... 61 ■ Transactivation activity of the X and PreS protein of duck hepatitis B virus are dispensible for DHBV infection in vitro and in vivo ................... 62 ■ Polyomavirus-encoded miRNAs .............................................................. 63 ■ A Global Analysis of Evolutionary Conservation Among Known and Predicted Gammaherpesvirus microRNAs ........................................ 65 ■ Monitoring the Epigenetic Fate of Gammaherpesvirus Genomes ............ 67 ■ A requirement for Drosha in the Maintenance of Kaposi's sarcoma-associated Herpesvirus Latency ................................................. 68 ■ A FACS-based FRET assay to analyze interactions between viral and cellular proteins in living cells .......................................................... 70 ■ Inhibition of Transferrin-Receptor Uptake by SIV and HIV Nef-alleles ...... 71 ■ Inefficient Nef-Mediated Downmodulation of CD3 and MHC-I Correlates with Loss of CD4+ T Cells in Natural SIV Infection ................. 72 ■ Single Nef Proteins from HIV-1 Subtypes C and F Fail to Up-Regulate Invariant Chain Cell Surface Expression .......................... 73 ■ Human Immunodeficiency Virus Type 1 Nef Expression Prevents AP-2-Mediated Internalization of the Major Histocompatibility Complex Class II-Associated Invariant Chain .............. 73 ■ Siglec expression on chimpanzee T-cells might contribute to the asymptomatic course of lentiviral infection in human primates ........ 75 ■ HIV-1 budding and persistence in macrophages ..................................... 75 ■ A serine phosphorylation site in HIV-1 Vpu is required for efficient counteraction of tetherin and replication in macrophages ... 77 ■ Viral determinants for AIDS-progression in pediatric HIV-1 subtype B and C infections .................................................................. 78 ■ Replication of ICP0-Null Mutant Herpes Simplex Virus Type 1 Is Restricted by both PML and Sp100 ..................................................... 78 ■ Duck Hepatitis B Virus Requires Cholesterol for Endosomal Escape during Virus Entry ............................................... 79 ■ Strong and selective inhibitors of hepatitis B virus replication among novel N4-hydroxy- and 5-methyl-beta-L-deoxycytidine analogues ........... 80 ■ Assembly and budding of a hepatitis B virus is mediated by a novel type of intracellular vesicles ........................................................ 81 ■ Avian Hepatitis B Viruses: Molecular and Cellular Biology, Phylogenesis and Host Tropism .............................................................. 82 ■ Efficiency of DHBV infection is restricted by an abortive entry pathway .. 83 ■ Secretion of duck hepatitis B virus occurs via exocytosis ......................... 83 ■ Naturally occurring adefovir resistance mutation rtI233V selected under adefovir therapy ............................................................. 85 ■ Cellular Determinants of HBV Replication ............................................... 85 ■ High resolution electron microscopical (EM)-analysis of the distribution of TNF receptor 1 ................................................................................... 86 ■ Cryotomography Ultrastructural analysis of cytomegalovirus tegument protein interactions ................................................................ 87 ■ Dynamic processes in organic and biological
Recommended publications
  • Oncogenes of DNA Tumor Viruses1
    [CANCER RESEARCH 48. 493-496. February I. 1988] Perspectives in Cancer Research Oncogenes of DNA Tumor Viruses1 Arnold J. Levine Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544 Experiments carried out over the past 10-12 years have the cellular oncogenes. It will attempt to identify where more created a field or approach which may properly be termed the information is required or contradictions appear in the devel molecular basis of cancer. One of its major accomplishments oping concepts. Finally, this communication will examine ex has been the identification and understanding of some of the amples of cooperation between oncogenes and other gene prod functions of a group of cancer-causing genes, the oncogenes. ucts which modify the mode of action of the former. If we are The major path to the oncogenes came from the study of cancer- on the right track, then general principles may well emerge. causing viruses. The oncogenes have been recognized and stud Tumor formation in animals or transformation in cell culture ied by two separate but related groups of virologists focusing has been demonstrated with many different DNA-containing upon either the DNA (1) or RNA (2) tumor viruses (they even viruses (1). In most cases it has been possible to identify one or have separate meetings now that these fields have grown so a few viral genes and their products that are responsible for large). From their studies it has become clear that the oncogenes transformation or, in some cases, tumorigenesis. A list of these of each virus type have very different origins.
    [Show full text]
  • Vaccination with Prion Peptide-Displaying Polyomavirus-Like Particles Prolongs Incubation Time in Scrapie-Infected Mice
    viruses Article Vaccination with Prion Peptide-Displaying Polyomavirus-Like Particles Prolongs Incubation Time in Scrapie-Infected Mice Martin Eiden 1,* , Alma Gedvilaite 2 , Fabienne Leidel 1,3, Rainer G. Ulrich 1 and Martin H. Groschup 1 1 Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Südufer 10, 17493 Greifswald-Insel Riems, Germany; [email protected] (F.L.); rainer.ulrich@fli.de (R.G.U.); martin.groschup@fli.de (M.H.G.) 2 Life Sciences Center, Institute of Biotechnology, Vilnius University, Sauletekio˙ al. 7, LT-10257 Vilnius, Lithuania; [email protected] 3 Task Force Animal Diseases, Darmstadt Regional Administrative Council, Luisenplatz 2, 64283 Darmstadt, Germany * Correspondence: martin.eiden@fli.de Abstract: Prion diseases like scrapie in sheep, bovine spongiform encephalopathy (BSE) in cattle or Creutzfeldt–Jakob disease (CJD) in humans are fatal neurodegenerative diseases characterized by the conformational conversion of the normal, mainly α-helical cellular prion protein (PrPC) into the abnormal β-sheet rich infectious isoform PrPSc. Various therapeutic or prophylactic approaches have been conducted, but no approved therapeutic treatment is available so far. Immunisation against prions is hampered by the self-tolerance to PrPC in mammalian species. One strategy to avoid this tolerance is presenting PrP variants in virus-like particles (VLPs). Therefore, we vaccinated C57/BL6 mice with nine prion peptide variants presented by hamster polyomavirus capsid protein VP1/VP2-derived VLPs. Mice were subsequently challenged intraperitoneally with the murine RML Citation: Eiden, M.; Gedvilaite, A.; prion strain. Importantly, one group exhibited significantly increased mean survival time of 240 days Leidel, F.; Ulrich, R.G.; Groschup, M.H.
    [Show full text]
  • Inhibition of HIV-1 by an Anti-Integrase Single-Chain Variable
    Gene Therapy (1999) 6, 660–666 1999 Stockton Press All rights reserved 0969-7128/99 $12.00 http://www.stockton-press.co.uk/gt Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection M BouHamdan1, L-X Duan1, RJ Pomerantz1 and DS Strayer1,2 1The Dorrance H Hamilton Laboratories, Center for Human Virology, Division of Infectious Diseases, Department of Medicine; and 2Department of Pathology, Anatomy and Cell Biology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA Human immunodeficiency virus type I (HIV-1) encodes the SFv-IN was confirmed by Western blotting and several proteins that are packaged into virus particles. Inte- immunofluorescence staining, which showed that Ͼ90% of grase (IN) is an essential retroviral enzyme, which has SupT1 T-lymphocytic cells treated with SV(Aw) expressed been a target for developing agents to inhibit virus repli- the SFv-IN protein without selection. When challenged, cation. In previous studies, we showed that intracellular HIV-1 replication, as measured by HIV-1 p24 antigen expression of single-chain variable antibody fragments expression and syncytium formation, was potently inhibited (SFvs) that bind IN, delivered via retroviral expression vec- in cells expressing SV40-delivered SFv-IN. Levels of inhi- tors, provided resistance to productive HIV-1 infection in bition of HIV-1 infection achieved using this approach were T-lymphocytic cells. In the current studies, we evaluated comparable to those achieved using murine leukemia virus simian-virus 40 (SV40) as a delivery vehicle for anti-IN (MLV) as a transduction vector, the major difference being therapy of HIV-1 infection.
    [Show full text]
  • Von Erwerbsarmut in Gute Arbeit
    From in-work poverty to Decent Work – Think European. Act in solidarity. #inworkNOpoverty Conference report Berlin, 25 September 2019 EUROPÄISCHE UNION Europäischer Sozialfonds Conference report: From in-work poverty to Decent Work 1 Table of Contents Page 2 Programme Page 6 Abstract Page 10 Welcome address Page 13 Welcome and Introduction Page 16 Keynote I – In-work poverty in comparative theory Page 20 Table Talks – Impressions Page 21 Talk in Pairs I – In-work poverty from the perspective of the people affected Page 23 Panel discussion I – In-work poverty – What answers does Europe have? Page 30 Keynote II – In-work poverty – Poor despite work Page 32 Talk in Pairs II – In-work poverty from the perspective of employees and employers Page 34 Workshop 1 – Precarious employment and in-work poverty Page 37 Workshop 2 – Digital transformation and in-work poverty Page 40 Workshop 3 – The service sector and in-work poverty Page 44 Workshop 4 – Vocational education and training and in-work poverty Page 48 Panel discussion II – In-work poverty – What answers exist for Berlin? Page 54 Conclusion – What can Berlin do – and what has Berlin already done? Page 56 Impressions Cover Back Imprint 2 Conference report: From in-work poverty to Decent Work Programme From in-work poverty to Decent Work – Think European. Act in solidarity. Organiser Senate Department for Integration, Labour and Social Services Date 25 September 2019 Location Hotel Stadtbad Berlin, Oderberger Straße 57, 10435 Berlin Moderation Dr Julia Kropf Throughout the conference (including
    [Show full text]
  • Hepatitis B Virus X Protein Inhibits P53 Sequence-Specific DNA Binding
    Proc. Nati. Acad. Sci. USA Vol. 91, pp. 2230-2234, March 1994 Medical Sciences Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3 XIN WEI WANG*, KATHLEEN FORRESTER*, HEIDI YEH*, MARK A. FEITELSONt, JEN-REN GUI, AND CURTIS C. HARRIS*§ *Laboratory of Human Carcinogenesis, Division of Cancer Etiology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; tDepartment of Pathology and Cell Biology, Jefferson Medical College, Philadelphia, PA 19107; and tDepartment of Molecular Biology and Biochemistry, Shanghai Cancer Institute, Shanghai, People's Republic of China. Communicated by Bert Vogelstein, December 27, 1993 (receivedfor review December 9, 1993) ABSTRACT Chronic active hepatitis caused by infection about the role of HBX in HCC development. In this report, with hepatitis B virus, a DNA virus, is a major risk factor for we present results consistent with the hypothesis that HBX human hepatocellular carcinoma. Since the oncogenicity of binds to p53 and abrogates its normal cellular functions. several DNA viruses is dependent on the interaction of their viral oncoproteins with cellular tumor-suppressor gene prod- MATERIAL AND METHODS ucts, we investigated the interaction between hepatitis B virus X protein (HBX) and human wild-type p53 protein. HBX Plasmids. Plasmid constructs encoding GST-p53-WT, con- complexes with the wild-type p53 protein and inhibits its taining glutathione S-transferase (GST) fused to human wild- sequence-specific DNA binding in vitro. HBX expresslin also type p53, and GST-p53-135Y, containing GST fused to the inhibits p53-mediated transcrptional activation in vivo and the mutant p53 containing a His -* Tyr mutation at codon 135, in vitro asoition of p53 and ERCC3, a general transcription were provided by Jon Huibregtse (National Cancer Institute) factor involved in nucleotide excision repair.
    [Show full text]
  • PP2A-Dependent Disruption of Centrosome Replication and Cytoskeleton Organization in Drosophila by SV40 Small Tumor Antigen
    Oncogene (2008) 27, 6334–6346 & 2008 Macmillan Publishers Limited All rights reserved 0950-9232/08 $32.00 www.nature.com/onc ORIGINAL ARTICLE PP2A-dependent disruption of centrosome replication and cytoskeleton organization in Drosophila by SV40 small tumor antigen S Kotadia1,LRKao1, SA Comerford2, RT Jones1, RE Hammer3 and TL Megraw1 1Department of Pharmacology, The Cecil and Ida Green Center for Reproductive Biology Sciences, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA; 2Department of Molecular Genetics, The Cecil and Ida Green Center for Reproductive Biology Sciences, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA and 3Department of Biochemistry, The Cecil and Ida Green Center for Reproductive Biology Sciences, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA Viruses of the DNA tumor virus family share the ability to cell-cycle and apoptosis regulation, viral oncoproteins transform vertebrate cells through the action of virus- transform cells. Investigation of DNA tumor virus encoded tumor antigens that interfere with normal cell oncoproteins has led to the identification of many physiology. They accomplish this very efficiently by fundamental mechanisms of tumor suppression (Lavia inhibiting endogenous tumor suppressor proteins that et al., 2003; Ahuja et al., 2005). By altering the activity control cell proliferation and apoptosis. Simian virus 40 of p53, retinoblastoma protein and serine/threonine (SV40) encodes two oncoproteins, large tumor antigen, protein phosphatase 2A (PP2A), three key tumor which directly inhibits the tumor suppressors p53 and Rb, suppressors, SV40 can cause tumor formation in and small tumor antigen (ST), which interferes with transgenic mouse models (Ahuja et al., 2005; Arroyo serine/threonine protein phosphatase 2A (PP2A).
    [Show full text]
  • The Simian Virus 40 Large Tumor Antigen Activates Csrc and Requires Csrc for Full Neoplastic Transformation
    ANTICANCER RESEARCH 30: 47-54 (2010) The Simian Virus 40 Large Tumor Antigen Activates cSrc and Requires cSrc for Full Neoplastic Transformation ROZANNE ARULANANDAM, MULU GELETU and LEDA RAPTIS Departments of Microbiology and Immunology and Pathology, Queen's University, Kingston, Ontario, K7L 3N6, Canada Abstract. Aim: To investigate the role of the cellular The effects of TAg on the Rb family proteins are thought to be protooncogene product, cSrc, in neoplastic transformation by exerted by regulating the activity of the E2F transcription factors. the large tumor antigen of simian virus 40 (TAg), the ability of There are eight known E2F proteins (E2F1-8), all of which TAg to increase cSrc activity was examined. Materials and possess a DNA-binding domain that governs their interactions Methods: cSrc activity was measured in cells expressing wild- with a common consensus sequence present in the promoters of type or mutant TAg and compared to the parental line. Results: a number of genes (reviewed in (4, 5)). In quiescent cells, E2F- The results indicated that TAg expression in mouse 3T3 regulated genes are not expressed because their promoters are fibroblasts causes a dramatic increase in cSrc activity, a finding occupied primarily by p130/E2F4 complexes which repress which establishes TAg as a cSrc activator. This ability transcription. Following receptor stimulation, Rb proteins are depended upon a TAg, intact retinoblastoma-susceptibility gene inactivated through phosphorylation by the cyclin-dependent product (Rb) family-binding site. In addition, genetic ablation kinases and this results in the replacement of the p130/E2F4 of pRb in mouse fibroblasts increased cSrc activity, suggesting complexes by the ‘activating’ E2F1-3.
    [Show full text]
  • Identification of a Novel Polyomavirus from Patients with Acute Respiratory Tract Infections Anne M
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2007 Identification of a novel polyomavirus from patients with acute respiratory tract infections Anne M. Gaynor Washington University School of Medicine in St. Louis Michael D. Nissen Royal Children’s Hospital, Brisbane, Queensland, Australia David M. Whiley Royal Children’s Hospital, Brisbane, Queensland, Australia Ian M. Mackay Royal Children’s Hospital, Brisbane, Queensland, Australia Stephen B. Lambert Royal Children’s Hospital, Brisbane, Queensland, Australia See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Part of the Medicine and Health Sciences Commons Recommended Citation Gaynor, Anne M.; Nissen, Michael D.; Whiley, David M.; Mackay, Ian M.; Lambert, Stephen B.; Wu, Guang; Brennan, Daniel C.; Storch, Gregory A.; Sloots, Theo P.; and Wang, David, ,"Identification of a novel polyomavirus from patients with acute respiratory tract infections." PLoS Pathogens.,. e64. (2007). https://digitalcommons.wustl.edu/open_access_pubs/872 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Anne M. Gaynor, Michael D. Nissen, David M. Whiley, Ian M. Mackay, Stephen B. Lambert, Guang Wu, Daniel C. Brennan, Gregory A. Storch, Theo P. Sloots, and David Wang This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/872 Identification of a Novel Polyomavirus from Patients with Acute Respiratory Tract Infections Anne M. Gaynor1, Michael D. Nissen2, David M.
    [Show full text]
  • Jahresbericht 2016
    1Jahresbericht 6 DZI 2016 – Auf einen Blick 2.182 Zeitschriften und 1.539 Bücher hat 300.000 Exemplare des die DZI Bibliothek bereitgestellt oder Spendenmagazins wurden ausgeliehen, sowie 2.254 Fotokopien von als Zeitungsbeilage über die Frankfurter Fachartikeln im Kundenauftrag hergestellt. Allgemeine Zeitung, das Handelsblatt, 4 die Berliner Morgenpost und die Süddeutsche Zeitung vertrieben. 9 232 Organisationen tragen Ende 2016 das DZI Spenden-Siegel. 821 Persönliche Auskünfte Das Volumen ihrer jährlichen Geldspenden gaben die Fachkräfte der beträgt Mrd. Euro (2013). 1,42 32 Bibliothek, davon 592 in Gesprächen und per E-Mail. 229 4 10.528 Ausgaben der 111.633 Einzelauskünfte Fachzeitschrift Soziale Arbeit zu insgesamt 380 Spenden- wurden verkauft, davon schon organisationen wurden online als . abgerufen. 5.702 E-Paper 6 9 1.695 individuelle Auskünfte gab die DZI Spender- 189.235 Besucher der . beratung 9 DZI-Website frequentierten 649.283 einmalige 231 Institutionen (meist Seitenansichten und riefen Hochschulen) haben die Literatur- 30.208 PDF-Dokumente ab. datenbank DZI SoLit abonniert 15 und können in 215.626 Büchern und Beiträgen aus Fachzeitschriften Der Förderverein recherchieren. 4 hat zur Unterstützung der 100-Eur Stiftung DZI 16.537 Euro ie o- D i Spenden-Sieg F be el- r ro Or a ausgegeben. 28 Eu ga g 0 n 0 is e 1 a t : n Projekte und io e n d r Programme e e n w d Die Jahreseinnahmen von 1,43 Mio. Euro u e i Euro r 87 c h W s stammten zu 54% aus eigenen c h n Werbung und i t Euro t Einnahmen und zu aus l 46% 13 i Verwaltung c h v e Zuwendungen.
    [Show full text]
  • So Ziale a Rbeit 11.2020
    RBEIT A SOZIALE SOZIALE 11.2020 Soziale Arbeit in Zeiten gesellschaftlicher Umbrüche | 404 Gemeinwesenarbeit und Corona | 411 Soziale Teilhabe von Menschen mit psychischen Erkrankungen | 416 Wohnen in der Wohnungs losigkeit | 425 Nachruf Bezirksamt Charlottenburg in der Familienfürsorge tätig. 1971 wechselte sie in die Senatsverwaltung für Jugend und Sport und übernahm dort die Leitung der Arbeitsgruppe Aufsicht und Beratung für Kinder- tagesstätten. Daneben absolvierte sie 1971 bis 1976 berufsbegleitend die Ausbildung zur Trainerin für Gruppendynamik und übernahm auch zahlreiche Lehraufträge an der Pädagogischen Hochschule Berlin und der Fachhochschule für Verwaltung und Rechtspflege. Ab 1976 wurde Ingrid Stahmer in ver- schie dene Funktionen in der SPD gewählt, sie gehörte dem Kreisvorstand Charlottenburg an, wurde Abtei- lungsvorsitzende, Landesdelegierte, Vorsitzende des Fachausschusses für Soziales und stellvertretende Prof. Ingrid Stahmer Landesvorsitzende.1981 und erneut 1985 wurde sie Bürgermeisterin a.D. und Senatorin a.D. zur Stadträtin für Sozialwesen und stellvertretenden Bezirksbürgermeisterin von Charlottenburg gewählt. Am 30. August 2020 starb plötzlich und uner- Von 1989 bis 1991 gehörte sie als Bürgermeisterin wartet Prof. Ingrid Stahmer, kurz vor Vollendung und Senatorin für Gesundheit und Soziales dem rot- ihres 78. Lebensjahres. Die frühere Bürgermeisterin grünen Senat von Walter Momper an, nach der Bil- von Berlin und Senatorin war mit Beschluss des Ber- dung der Großen Koalition 1991 gab sie das Bürger- liner Senats vom 27. Februar 1990 in das Amt der meisteramt und das Gesundheitsressort an Ost-Ber - Vorstandsvorsitzenden der Stiftung Deutsches Zen- liner Senatsmitglieder ab, blieb aber Senatorin für tralinstitut für soziale Fragen (DZI) berufen worden Soziales. Im November 1994 übernahm sie zusätzlich und übte dieses Amt bis zu ihrem Tod aus.
    [Show full text]
  • Identification of Rab18 As an Essential Host Factor for Bkpyv Infection Using a Whole Genome RNA 2 Interference Screen
    bioRxiv preprint doi: https://doi.org/10.1101/157602; this version posted June 29, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Identification of Rab18 as an Essential Host Factor for BKPyV Infection Using a Whole Genome RNA 2 Interference Screen 3 4 Linbo Zhaoa, Michael J. Imperialea,b,* 5 6 aDepartment of Microbiology and Immunology, bComprehensive Cancer Center, University of Michigan, 7 Ann Arbor, MI, 48109, USA 8 9 10 11 12 13 14 15 16 17 18 * Corresponding author. Department of Microbiology and Immunology, 1150 West Medical Center 19 Drive, 5724 Medical Science II, Ann Arbor, MI 48109-5620, USA. Tel. +1 (734) 763 9162. Fax: +1 (734) 20 764 3562. 21 E-mail addresses: [email protected] (L. Zhao); [email protected] (M.J. Imperiale). 22 23 24 1 bioRxiv preprint doi: https://doi.org/10.1101/157602; this version posted June 29, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 25 Abstract 26 27 BK polyomavirus (BKPyV) is a human pathogen first isolated in 1971. BKPyV infection is ubiquitous in the 28 human population, with over 80% of adults worldwide being seropositive for BKPyV. BKPyV infection is 29 usually asymptomatic; however, BKPyV reactivation in immunosuppressed transplant patients causes 30 two diseases, polyomavirus-associated nephropathy and hemorrhagic cystitis.
    [Show full text]
  • DER SPIEGEL Jahrgang 1995 Heft 34
    Werbeseite Werbeseite MNO DAS DEUTSCHE NACHRICHTEN-MAGAZIN Hausmitteilung Betr.: Günter Grass ine Blechtrommel war nichts dagegen: Mit gewaltigen Paukenschlägen Ekündigte der Göttinger Steidl Verlag dieses „Opus magnum“ an – das jüngste Buch des Günter Grass, berühmtester unter den lebenden deut- schen Schriftstellern, dem der SPIEGEL nun zum viertenmal eine Titelge- schichte widmet. Zeitig und exklusiv sicherte sich der SPIEGEL die Rech- te für einen Vorabdruck etlicher Passagen aus dieser Neuheit, „Ein weites Feld“. Doch als es dann etwas zu lesen gab, kamen Chef- und Kulturre- daktion in Verlegenheit. Die zum Abdruck gedachte Romanstrecke er- wies sich als ein überaus sperriger Kurs durch deutsche Geschichte, und selbst dem besonders bemühten, literarisch bewander- ten Leser mußte es da schwerfallen, zwi- schen den Bruchstücken eine Richtung zu erkennen. Da zudem der Verlag um die 4500 Exemplare des „Jahrhundertwerks“ (dpa) im Vorwege an die Fachwelt verteil- te, war auch von der Exklusivität nicht viel übriggeblieben. Gute Gründe also, auf den Teilabdruck zu verzichten, doch bei den Betroffenen hörte es sich anders an. Rudolf Augstein, wurde Grass-Titel (1963) kolportiert, habe sein Veto eingelegt, und zwar auch deshalb, so hieß es allen Ernstes, weil er mit Grass in Fragen der deutschen Vereinigungspolitik über Kreuz sei. Als der SPIEGEL den Vorabdruck des „Weiten Feldes“ ablehnte, hatte Augstein gerade mal ein Viertel davon überflogen, und die Vorstellung, politischer Dissens trübe bei ihm das literarische Urteil, ist nun wohl allzu naiv. Augstein hatte schon 1966 das Anti-Brecht-Stück von Grass „Die Plebejer proben den Aufstand“ im SPIEGEL rezensiert. Dennoch war es vom Steidl Verlag werbetechnisch nicht ungeschickt zu insinu- ieren, der neue Grass sei dem SPIEGEL politisch zu suspekt, gar zu brisant.
    [Show full text]